Autolus Therapeutics to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6
LONDON, July 30, 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its second quarter 2020 financial results and operational highlights before open of U.S. markets on Thursday, August 6, 2020.
Management will host a conference call and webcast at 8:30 am ET/1:30 pm BST to discuss the company’s financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to: https://www.autolus.com/investor-relations/news-and-events/events.
To access the live and subsequent replay of this webcast that will be live for two weeks and view the accompanying slide presentation, please register here.
Lucinda Crabtree, PhD
Susan A. Noonan
IoT Evolution #TECHSUPERSHOW Expo Hall Open
Autonomation and Predictability in IIoT